Farther Finance Advisors’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

Farther Finance Advisors’s Portfolio DCPH Stock Details DCPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-74	Closed	-$1.17K	–	3951
2024 Q1	$1.17K	Buy	74 +5	+7%	+$77	﹤0.01%	2708
2023 Q4	$1.11K	Buy	69 +64	+1,280%	+$816	﹤0.01%	2675
2023 Q3	$64	Buy	+5	New	+$69	﹤0.01%	2562

Other funds holding DCPH

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Farther Finance Advisors's DCPH Position: Q2 2024 in Review

Farther Finance Advisors sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q2 2024, closing a stake of 74 shares — an estimated $1.17K sold.

Farther Finance Advisors first reported a position in DCPH in Q3 2023 and held it in 3 quarters. The position peaked at $1.17K in Q1 2024. 1 fund tracked by Wall St. Rank holds DCPH as of Q2 2024.

Farther Finance Advisors reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
Farther Finance Advisors sold 74 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q2 2024, an estimated $1.17K.
Farther Finance Advisors first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q3 2023 and held it in 3 quarters.
Farther Finance Advisors's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $1.17K in Q1 2024.
1 fund tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q2 2024.

Based on Farther Finance Advisors's 13F filing for Q2 2024, filed 31 Jul 2024.